MannKind | MNKD - Des Atouts

Prix De L'Action
2.50
Variation Quotidienne
-0.11 -4.06%
Mensuellement
-54.80%
Annuel
-52.40%
Q1 Prévisions
2.69




Des Atouts Changement Date
Adma Biologics USD 624.24M 55.56M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
MacroGenics USD 256.85M 13.92M 2025-12
MannKind USD 792.18M 297.54M 2025-12
Merck USD 129.55B 12.02B 2025-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Novavax USD 1.18B 3.38M 2025-12
Novo Nordisk DKK 76.18B 412.98B 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Sanofi EUR 126.81B 2.99B 2025-12
Xencor USD 875.5M 6.68M 2025-12